What are the treatment options for menopause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Menopause

For women experiencing menopausal symptoms, hormone therapy is the most effective treatment option for vasomotor symptoms, but non-hormonal alternatives should be considered first-line for most women due to potential risks associated with hormone therapy. 1

Assessment of Menopausal Symptoms

  • Menopausal symptoms can include hot flashes/night sweats, vaginal dryness, urinary complaints, sexual dysfunction, sleep disturbance, mood disturbance, depression, cognitive dysfunction, arthralgias/myalgias, and fatigue 2
  • Laboratory evaluation may include estradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin, as clinically indicated 2
  • FSH is not a reliable marker of menopausal status in women with prior chemotherapy, pelvic radiation exposure, or those on tamoxifen 2

Non-Pharmacological Treatments

Lifestyle Modifications

  • Dress in layers to easily remove clothes during hot flashes 2
  • Wear natural fibers and use cold packs intermittently 2
  • Identify and avoid potential triggers (e.g., spicy food, hairdryers, anxiety) by keeping a hot flash diary 2
  • Exercise may reduce the risk or ameliorate hot flashes in some women 2
  • Achieve a healthy weight and stop smoking, as hot flashes may be more severe in overweight women and smokers 2

Complementary and Alternative Therapies

  • Evidence for herbal remedies is inconsistent and inconclusive 2, 3
  • High-dose vitamin E (800 IU/day) has shown limited efficacy for mild vasomotor symptoms 2
  • Soy products may provide modest improvement in hot flashes and vaginal dryness 4
  • Clinical hypnosis has shown significant reduction in hot flashes in small studies 4
  • Acupuncture shows mixed results, with some studies suggesting it is superior to placebo but less effective than estrogen for hot flashes 2

Pharmacological Treatments

Non-Hormonal Medications

For Vasomotor Symptoms

  • Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are effective alternatives for women who cannot or will not use hormone therapy 2

    • Paroxetine (7.5 mg daily) has been shown to reduce frequency and severity of vasomotor symptoms 2
    • Venlafaxine is also effective for hot flashes 2
    • Caution: SSRIs, particularly paroxetine, should be used with caution in women taking tamoxifen due to potential drug interactions 2
  • Gabapentin is effective for severe hot flashes 2

  • Clonidine may be considered for mild to moderate hot flashes 2

For Genitourinary Symptoms

  • Non-hormonal vaginal moisturizers for vaginal dryness 4
  • Ospemifene (the only FDA-approved non-hormonal treatment for dyspareunia due to menopausal atrophy) 4

Hormone Therapy

Menopausal Hormone Therapy (MHT)

  • Most effective treatment for vasomotor symptoms 1

  • General recommendations:

    • Combination estrogen and progestin for women with an intact uterus 2
    • Estrogen alone for women without a uterus 2
    • Use the lowest effective dose for the shortest possible time 2
  • Benefits:

    • Effective relief of hot flashes 2
    • Reduces risk of fractures 2
    • May improve quality of life 5
  • Risks:

    • Combined estrogen/progestogen therapy increases risk of breast cancer when used for more than 3-5 years 4
    • Increased risk of venous thromboembolism, coronary heart disease, and stroke within the first 1-2 years of therapy 2
    • Estrogen-only therapy is associated with increased risk of stroke, deep vein thrombosis, and gallbladder disease 2
  • Contraindications:

    • History of hormone-related cancers 2
    • History of abnormal vaginal bleeding 2
    • Recent history of pregnancy 2
    • Active liver disease 2

Local Estrogen Treatments

  • Vaginal rings, suppositories, or creams for genitourinary symptoms 2
  • Lower systemic absorption compared to oral hormone therapy 4

Selective Estrogen Receptor Modulators (SERMs)

  • Raloxifene acts as an estrogen agonist in bone, decreasing bone resorption and turnover, increasing bone mineral density, and decreasing fracture incidence 6
  • Combined formulation of estrogen and bazedoxifene (a SERM) may benefit women who cannot tolerate adverse effects of progestogens 4

Treatment Algorithm

For Vasomotor Symptoms:

  1. Mild symptoms:

    • Start with lifestyle modifications 2
    • Consider vitamin E or clonidine 2
  2. Moderate to severe symptoms:

    • First-line (non-hormonal): SSRIs/SNRIs or gabapentin 2
    • Second-line (if non-hormonal treatments fail): Consider hormone therapy if no contraindications exist 2, 1
      • For women with intact uterus: Estrogen plus progestin 2
      • For women without uterus: Estrogen alone 2

For Genitourinary Symptoms:

  1. First-line: Non-hormonal vaginal moisturizers and lubricants 4
  2. Second-line: Low-dose vaginal estrogen or ospemifene 4

Important Considerations and Caveats

  • Benefits of hormone therapy may exceed risks for symptomatic women under age 60 or within 10 years of menopause onset 1
  • Hormone therapy should not be used for prevention of chronic diseases such as coronary heart disease, breast cancer, or dementia 2, 1
  • Women who decide to take hormone therapy for menopausal symptoms should use the lowest effective dose for the shortest possible time 2
  • There is no high-quality evidence supporting the claim that custom-compounded bioidentical hormones are safer or more effective than standard hormone therapies 2
  • The decision to use hormone therapy should be based on a thorough evaluation of the risks and benefits for each individual woman 4

References

Research

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of perimenopausal and menopausal symptoms.

BMJ (Clinical research ed.), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.